Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286776 · ClinicalTrials.gov registry record · NA
Memory Retrieval and Encoding Investigated by Neural Stimulation
A NA study of Epilepsy Intractable, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 11
- Study locations
NCT04286776 is a NA study of Epilepsy Intractable that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 800 participants, above the 119-participant average among 3 other Epilepsy Intractable trials with a reported enrollment target (572% higher). The trial reports 11 study locations across 9 states.
The verdict
NCT04286776, a NA study of Epilepsy Intractable, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.
Conditions Studied
Interventions
- DEVICE Direct electrical stimulation
Study Locations (11)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Thomas Jefferson University Hospital - Philadelphia
Texas
- UT Southwestern Medical Center - Dallas
- University of Texas Health Science Center at San Antonio - San Antonio
Colorado
- University of Colorado, Denver - Aurora
Georgia
- Emory University Hospital - Atlanta
Maryland
- National Institute of Neurological Disorders and Stroke - Bethesda
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Mayo Clinic - Rochester
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2014-10-12 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04286776
The ClinicalTrials.gov registry entry for NCT04286776 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 3 other Epilepsy Intractable trials with a reported enrollment target (572% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy Intractable appearing as the primary indexed condition, and to 1 intervention - of which Direct electrical stimulation is the first listed.
NCT04286776 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Pennsylvania, Texas, Colorado.
Frequently Asked Questions
What is clinical trial NCT04286776 about?
NCT04286776 is a clinical study titled "Memory Retrieval and Encoding Investigated by Neural Stimulation". The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.
What is the current status of trial NCT04286776?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2014-10-12. Estimated completion is 2024-12-31.
What conditions does trial NCT04286776 study?
This clinical trial studies the following conditions: Epilepsy Intractable.
What interventions are being tested in trial NCT04286776?
The interventions under investigation include: Direct electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT04286776?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04286776 being conducted?
This trial has 11 study locations across Colorado, Georgia, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy Intractable
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural Mechanisms of Spatial Representations Beyond the Self
RECRUITING · NA
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
-
Localizing Epileptic Networks Using MRI and iEEG
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.